MARLES GEIST: Open Payments
NPI 1073759486 · CHEHALIS, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$138 in 5 payments from 4 companies in 2025. Trend: 2023 $135 · 2024 $44 · 2025 $138
Food & beverage: $138
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $54 |
| GENZYME CORPORATION | 1 | $38 |
| Lilly USA, LLC | 1 | $28 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
Products named: EPKINLY, SARCLISA, VERZENIO, CALQUENCE.
Industry payments across WA — which companies pay providers there.
